Stanford University
Showing 9,601-9,700 of 13,016 Results
-
Eunice Rodriguez
Professor (Teaching) of Pediatrics (General Pediatrics)
On Partial Leave from 2026-09-15 To 2026-12-31Current Research and Scholarly InterestsCurrent program of teaching and research integrates: 1) health disparities and social epidemiology, within the broader area of public health, and 2) program evaluation, as a synthesis of theory and methods applied to the evaluation of health and social programs.
-
Fatima Rodriguez
Robert and Shirley Raymer Professor
BioFatima Rodriguez, MD, MPH serves as the Vice Chair of Clinical Research (Department of Medicine), Section Chief of Preventive Cardiology, and Associate Director of the Center for Digital Health at Stanford University. She received her medical degree from Harvard Medical School and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Dr. Rodriguez completed her internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford.
Dr. Rodriguez specializes in the prevention and management of cardiovascular disease, with clinical expertise in coronary artery disease and inherited lipid disorders. Her research focuses on cardiovascular disease prevention and health promotion, leveraging digital tools to improve guideline-based care, and using AI-enabled approaches for early detection of atherosclerosis. -
Samuel Rodriguez, MD
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Sam Rodriguez is a native of New Jersey and practicing Pediatric Anesthesiologist at Stanford Children's Hospital. He is best known for being the husband of the Stanford Cardiologist Dr. Fatima Rodriguez. Sam was a member of the self proclaimed greatest Anesthesia Residency Class in history (MGH 2012). He is a founder and co-director of the Stanford CHARIOT Program which creates and studies innovative approaches to treating pediatric pain and stress through technology. The CHARIOT Program has positively impacted thousands of children around the world and has grown to include emerging technologies like virtual reality, augmented reality, and interactive video games. Dr. Rodriguez is also highly involved in medical humanities education at Stanford Medical School and teaches courses at the undergraduate and graduate levels on how studying art can make better physicians.
-
Patricia Rodriguez Espinosa
Assistant Professor of Epidemiology and Population Health
BioDr. Patricia Rodriguez Espinosa, PhD., MPH, is an Assistant Professor in the Department of Epidemiology and Population Health and also serves as the Associate Director of Research for the Office of Community Engagement at Stanford Medicine. Dr. Rodriguez Espinosa is also the Associate Core Lead for the Outreach, Recruitment, and Engagement Core of the Stanford Alzheimer's Disease Research Center. The ultimate goal of her research is to improve the health of diverse populations - including Latinxs, under-resourced communities, and older adults - through transdisciplinary and community-engaged scholarship. Her research aims to develop novel multi-level interventions and health promotion programs to improve health outcomes (e.g., around aging, multiple chronic conditions, cardiovascular disease) and that include multi-sectoral collaborations. Dr. Rodriguez Espinosa's research has also centered around developing the science of Community-Based Participatory Research, citizen/community science, and other participatory research approaches.
-
Daniela Rodriguez Martinez
Assistant Manager, Communications, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordAssistant Manager, Communications @Stanford Byers Center for Biodesign
-
Kacper Rogala
Assistant Professor of Structural Biology and of Chemical and Systems Biology
Current Research and Scholarly InterestsOur team is fascinated by how cells make growth decisions — to grow or not to grow. In order to grow, cells require nutrients, and we are unraveling how cells use specialized protein sensors and transporters to sense and traffic nutrients in between various compartments. We use approaches from structural biology, chemical biology, biophysics, biochemistry, and cell biology — to reveal the mechanisms of basic biological processes, and we develop chemical probes that modulate them.
-
Albert "A.J." Rogers, MD, MBA, FAHA, FHRS
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is Assistant Professor of Medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.
As a clinical cardiac electrophysiologist, Dr. Rogers’ expertise includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). This includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.
Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.
As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 15 years of experience with medical technology innovation and development.
Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society. -
Angela Rogers
Professor-Univ Med Line, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.
-
India Bahia Rogers-Shepp
Resident in Obstetrics & Gynecology
BioIndia Rogers-Shepp is originally from New York City. She graduated from Princeton University with her BA in molecular biology in 2018 and a certificate in Dance. The following year she graduate from Brown University with a Master's in Science in Medical Sciences in 2019. She entered Stanford Medical School in 2020. During her time here, she has pursued her passions for women's health, queer health, equity for the unhoused, and environmental justice. India's future career goal is to become an OB/GYN who centers the reproductive health of the unhoused and those made most vulnerable by climate change through her clinical practice and research.
-
Alissa Megan Rogol
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioAcademic interests include child and adolescent psychiatry, forensic psychiatry, medical ethics and palliative care.
-
Eugene Y. Roh, MD
Clinical Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsTherapeutic Efficacy of biologic treatments(Platelet Rich Plasma, adipose, mfat, bone marrow, stem cell) in OA and tendonitis
Application of musculoskeletal ultrasound for sports medicine and other musculoskeletal disease.
AI-based musculoskeletal diagnosis and treatment in sports, OA and tendinitis -
Nidhi Rohatgi, MD MS
Clinical Professor, Medicine
Clinical Professor (By courtesy), Neurosurgery
Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain MedicineBioNidhi Rohatgi, MD, MS, SFHM, is a Clinical Professor of Medicine and (by courtesy) Neurosurgery, Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine. She served as Chief of Surgical Co-management for Neurosurgery, ENT, and Orthopedic Surgery at Stanford. Dr. Rohatgi is Affiliate Faculty at Stanford's Center for Artificial Intelligence in Medicine and Imaging (AIMI) and Center for Digital Health. She served as Co-Director of Clinical Research in Hospital Medicine and Physician Lead of Stanford Health Care's Readmissions Committee.
Dr. Rohatgi has authored peer-reviewed articles in high-impact journals (NEJM, Lancet, JAMA, Nature, Annals of Surgery), led workshops and webinars, and written book chapters in Perioperative Medicine. She is a global advisor on surgical co-management models and chaired the Society of Hospital Medicine's Global Technical Advisory Committee on co-management. Dr. Rohatgi serves as the Editor-in-Chief for JMIR Perioperative Medicine journal and is on the Editorial Board for Brown University's Journal of Hospital Medicine. She has been an invited faculty/keynote speaker at several regional, national, and international meetings.
Dr. Rohatgi has served as Medical Director for Clinical Advice Services in Patient Experience at Stanford for over 10 years, overseeing after-hours clinical support and triage for 30+ services and 180+ clinics, and handling 90,000+ calls annually. This award-winning service has a strong track record in patient safety, reducing unnecessary ED and clinic visits, and reducing pages to on-call teams by over 90%.
She has served on multiple national committees: Society of Hospital Medicine's Research Committee, Hospital Quality and Patient Safety Committee, Perioperative Medicine Executive Council, Practice Management Committee, Perioperative and Consultative Medicine Educational Portal Planning Committee, and Leadership Committee for the Hospital Medicine National Writing Challenge. Dr. Rohatgi has served as a principal investigator and co-investigator for NIH and industry-sponsored trials. Recognized as a Top Hospitalist by the American College of Physicians, she has received numerous national and international awards for clinical care, quality improvement, teaching, and research.
Dr. Rohatgi has written on LLMs for clinical text summarization and pharmacogenomics, multimodal in-context learning (presented at NeurIPS), promises and limitations of AI, and digital twins. She was the keynote speaker on Engineering AI for Real Clinical Impact at the 2026 IEEE International Conference on Sustainability, Innovation, and Technology. In her upcoming book, Dr. Rohatgi shares a blueprint for AI in medicine: where AI can help and how, global health AI trends, and tackling costs. Her unique lens spans clinical experience in rural India to Silicon Valley, managing patients in medical and surgical specialties, research on millions of patient records, investigator for clinical trials, patient experience, clinical triage, and health system operations. Dr. Rohatgi is passionate about innovative, value-based, sustainable solutions, and exploring new frontiers in healthcare. -
Rajat Rohatgi
Professor of Biochemistry and of Medicine (Oncology)
Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.
-
Benjamin Rolles
Postdoctoral Scholar, Hematology
BioMD/Research Fellow
@MullallyLab @StanfordMed @VAPaloAlto @BrighamHeme @BrighamResearch @HarvardMed
Studied
@UniklinikAachen @RWTH
Interested in MPN & Myeloid Malignancies -
Dana Nirel Romalis
Clinical Assistant Professor, Medicine - Vaden Health Center
BioDana Romalis has been a board certified Family Medicine physician since 2004. She enjoys taking care of people throughout all phases of life. Special interests include teaching, collaborative care, preventative medicine, behavioral change, and reproductive and adolescent health. Since 2017, she has been a clinician educator with Stanford's department of primary care and population health. Her current clinical practice is at the Vaden student health center on campus.
She was born and raised in Vancouver, Canada, where she also attended medical school at the University of British Columbia. As an undergraduate at Brandeis University, she double majored in Neuroscience and Psychology, and was captain of the women’s varsity diving team. She did her residency at Montefiore Medical Center’s Residency Program of Social Medicine in the Bronx, NY.
Prior to joining Stanford’s primary care division in 2017, she was a primary care physician on Santa Clara Valley Medical Center's interdisciplinary Homeless Healthcare Program for 10 years. She is committed to comprehensive and compassionate care for all.
In her spare time, she enjoys spending time with her husband and 2 adult children, reading, hiking, and volunteering in her community. -
Maria Grazia Roncarolo
George D. Smith Professor of Stem Cell and Regenerative Medicine, Emerita
Current Research and Scholarly InterestsResearch Interests
Immunetolerance: Mechanisms underlying T-cell tolerance, induction of T-cell anergy and regulatory T cells; Immunomodulation: mAbs, proteins and low molecular weight compounds which can modulate T-cell activation; Primary immunodeficiencies: Characterization of molecular and immunological defects; Gene therapy: Gene transduction of hematopoietic cells for gene therapy in primary immunodeficiencies and metabolic diseases; Hematopoiesis: Mechanisms underlying growth and differentiation of hematopoietic stem cells; Transplantation: Immune reconstitution and T-cell tolerance after allogenic stem cell transplantation; Cytokines/Cytokine receptors: Role in regulation of immune and inflammatory responses
Clinical Interests
Primary Immunodeficiencies
Monogenic Autoimmune Disorders
Allogenic Bone Marrow Transplantation
Gene Therapy Clinical Trials
Cell Therapy Clinical Trials
Clinical Trials in Autoimmune Diseases and Organ Transplantation
Clinical Trials in Hemoglobinopathies -
Andrew Rong, MD
Associate Professor of Ophthalmology (Research/Clinical Trials)
BioDr. Andrew J. Rong is a board-certified, fellowship-trained oculofacial plastic, reconstructive, and orbital surgeon with Stanford Health Care. He is also an associate professor in the Department of Ophthalmology, Division of Oculoplastic, Reconstructive, and Orbital Surgery at Stanford University School of Medicine.
Dr. Rong has extensive expertise in cosmetic, functional, and reconstructive eyelid surgery. He specializes in upper and lower blepharoplasty, ptosis repair, revision eyelid surgery, brow lifting, and natural-looking periocular rejuvenation. He also treats eyelid tumors, eyelid malposition, thyroid eye disease, orbital tumors, and other complex conditions affecting the eyelids and eye socket. Dr. Rong performs advanced eyelid and periocular reconstruction following trauma, cancer treatment, and previous surgery. Whether performing cosmetic or reconstructive eyelid surgery, he provides individualized care designed to preserve eyelid function while achieving balanced, natural-looking results.
Dr. Rong graduated summa cum laude from the University of California, Los Angeles, with a degree in Microbiology, Immunology, and Molecular Genetics. He received his medical degree from the University of California, Davis, where he was elected to the Alpha Omega Alpha Honor Medical Society. He completed both his ophthalmology residency and oculoplastic surgery fellowship at Bascom Palmer Eye Institute. He subsequently joined the faculty at Bascom Palmer and served as Director of the Oculoplastic, Reconstructive, and Orbital Surgery Division, leading one of the country’s largest academic oculoplastic surgery services before returning to his native California and joining Stanford.
A major focus of Dr. Rong’s academic work is oculoplastic oncology, particularly sebaceous carcinoma of the ocular adnexa. His research seeks to improve how eyelid and periocular cancers are detected, characterized, and treated through molecular diagnostics, biomarker discovery, and translational laboratory models. His work has advanced the understanding of sebaceous carcinoma biology, including the identification of novel diagnostic markers and investigation of emerging therapeutic approaches. Dr. Rong has also developed and published innovative surgical techniques for complex eyelid, ocular surface, orbital, and periocular reconstruction, including reconstruction following lacrimal and periocular tumor resection.
Dr. Rong has authored numerous peer-reviewed publications, abstracts, and book chapters. He has lectured nationally and internationally on eyelid and periocular cancers, sebaceous carcinoma, ocular surface reconstruction, orbital surgery, cosmetic oculofacial surgery, and complex oculoplastic techniques. His research has been supported by grant and philanthropic funding and published in leading ophthalmology journals.
Dr. Rong is a member of the American Society of Ophthalmic Plastic and Reconstructive Surgery and has been recognized as a Castle Connolly Top Doctor. Outside of medicine, he enjoys spending time with his wife and two young daughters. -
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox). -
Michal Bental Roof
Academic Prog Prof 3, Pediatrics - Cardiology
Current Role at StanfordI joined the Cardiopulmonary Research Program of Drs. Rabinovitch and Bland at Stanford University in 2002, as the Academic and Research Program Officer, and since 2020 assumed my role at the Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, directed by Dr. Rabinovitch. I organize the educational activities of the lab, and assist the faculty and fellows with the preparation of grant proposals, IRB, APLAC and Biosafety protocols, manuscripts, and presentations. I served as the Site Coordinator for the Stanford Transplant Procurement Center of the Pulmonary Hypertension Breakthrough Initiative (PHBI), headed by Dr. Rabinovitch,that now evolved into the Stanford Transplant Tissue Bank. In this capacity, I oversee patient recruitment, data collection and reporting, and ensure compliance with university and federal guidelines. I coordinated and prepared the application for an Investigational New Drug (IND) and the pre-IND meeting that preceded that, for Elafin as a therapy for pulmonary arterial hypertension (PAH) to the FDA in August 2017, and with the Study PIs coordinated the Phase 1 clinical trial “Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects” that followed.
From 2005-2015, I served as the Administrative Coordinator of the Cardiovascular and Pulmonary Science Scholarly Concentration for medical students at Stanford University School of Medicine. This includes facilitating communication of the four co-Directors with the School of Medicine Administration, the medical students, and the faculty mentors. An important component of this role is the coordination of the MED223 course, a medical school course where faculty and fellows present new developments in cardiovascular science in the form of a journal club. From 2013-2018, I was the coordinator for the NIH-NHLBI T32 “Mechanisms and Innovation in Vascular Disease” (PI: RL Dalman), and from 2013 to date for NIH-NHLBI K12 HL120001 “Stanford Career Development Program in ‘Omics’ of Lung Disease”. (PIs: M Rabinovitch, MR Nicolls and MP Snyder). This included recruitment of candidates, oversight of training activities, ensuring compliance with NIH and Stanford policies, and acting as a liaison between the trainees and the Directors to facilitate effective communication.
Prior to joining Stanford, I was Associate Director (Scientific Development Administrator) at the Institute for Medicine and Engineering, directed by Dr. Peter Davies at the University of Pennsylvania. In this role, I was the liaison with federal funding agencies and organized multi-investigator program projects and training grants. -
Johanna S. Rosado Lozoya
Postdoctoral Scholar, Dermatology
BioDr. Johanna Rosado is a postdoctoral researcher in dermatology, mentored by Dr. Anne Chang and Dr. Zakia Rahman, studying skin frailty as a potential window into systemic disease, aging, and healthspan. Originally trained as a physician in Mexico City, she has four years of clinical experience in plastic and reconstructive surgery, primary care, and community health.
Her research focuses on understanding how skin frailty reflects broader changes in health, function, and resilience. She is also interested in skin cancer prevention, combating health misinformation, and translating evidence into accessible, actionable information that supports healthy aging.
As a New Maps of Life Fellow, she hopes to advance interdisciplinary and community-engaged approaches to promote healthier aging, and support function and quality of life across the lifespan. Her long-term goal is to integrate dermatology, prevention, and community engagement to advance a more proactive model of healthcare focused not only on treating disease, but on helping people maintain health, independence, and well-being throughout life. -
Lisa Goldman Rosas
Associate Professor (Research) of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics
BioLisa Goldman Rosas, PhD MPH is an Associate Professor in the Department of Epidemiology and Population Health and the Department of Medicine, Division of Primary Care and Population Health at Stanford School of Medicine. An epidemiologist by training, Dr. Goldman Rosas’ research focuses on addressing disparities in diet-related chronic diseases such as diabetes, heart disease, depression, and cancer especially for those who face food insecurity. This research features rigorous quantitative and qualitative methodologies, participatory qualitative approaches, and shared leadership with patient and community partners. She is passionate about integrating patients, caregivers, community organizations, and other key stakeholders in the research process in order to affect the greatest improvements in health and well-being. As a reflection of this passion, Dr. Goldman Rosas serves as the Faculty Director for the School of Medicine Office of Community Engagement, Co-Director of Community-Engaged Research for the Office of Cancer Health Equity, and Director of the Outreach, Recruitment and Engagement Core for the Alzheimer's Disease Research Center. In these roles, she supports other faculty and patient and community partners to develop sustainable and meaningful partnerships to support transformative research. In addition to research, she teaches at the undergraduate and graduate levels and has a special focus on increasing capacity in community engagement methods.
-
Christian Rose, MD
Assistant Professor of Emergency Medicine (Adult Clinical/Academic)
Current Research and Scholarly InterestsUncertainty permeates the practice of emergency medicine. I want to answer the question: what do you do when you don't know what to do?
-
Jessica Rose
Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Rose's research investigates neuromuscular mechanisms underlying cerebral palsy (CP) and early brain and motor development in preterm children. Research examines gait biomechanics as well as neonatal brain microstructure on DTI, physiology and motor function in CP. Dr. Rose served on NIH Taskforce on Childhood Motor Disorders, AACPDM Research Committee, NIH Steering Committee on CDE for CP neuroimaging diagnostics, BOD of SBMT and serves on the IAACD Research Committee.
-
Kevin Rose
Postdoctoral Scholar, Structural Biology
Current Research and Scholarly InterestsI am interested in studying organelle dysfunction and host cell responses at the highest resolution possible in natively preserved tissues. To do this, I couple correlative light and cryo-Electron Tomography (cryo-ET) and perform ultrastructural analysis of healthy and diseased organelles. This technique hopes to uncover new molecular details of pathophysiology so that we can improve our understanding of diseases such as cancer and neurodegeneration to improve the rationale therapeutic design.
-
Sherri Rose
Professor of Health Policy and, by courtesy, of Computer Science
BioSherri Rose, Ph.D. is a Professor of Health Policy and, by courtesy, of Computer Science at Stanford University, where she is Director of the Health Policy Data Science Lab. Her research is centered on developing and integrating innovative statistical machine learning approaches to improve human health. Within health policy, Dr. Rose works on algorithms in health care, risk adjustment, chronic kidney disease, and health program evaluation. She has published interdisciplinary projects across varied outlets, including Biometrics, Journal of the American Statistical Association, Journal of Health Economics, Health Affairs, and New England Journal of Medicine. In 2011, Dr. Rose coauthored the first book on machine learning for causal inference, with a sequel text released in 2018.
Dr. Rose has been honored with an NIH Director’s Pioneer Award, NIH Director's New Innovator Award, the ISPOR Bernie J. O'Brien New Investigator Award, and multiple mid-career awards, including the Gertrude M. Cox Award. She is a Fellow of the American Statistical Association (ASA) and received the Mortimer Spiegelman Award, which recognizes the statistician under age 40 who has made the most significant contributions to public health statistics. In 2024, she received both the ASHEcon Willard G. Manning Memorial Award for Best Research in Health Econometrics and the ASA Outstanding Statistical Application Award. She was recently awarded the Open Science Champion Prize by Stanford University. Her research has been featured in The New York Times, USA Today, and The Boston Globe. She was Co-Editor-in-Chief of the journal Biostatistics from 2019-2023. -
Jennifer Rose-Nussbaumer
Alan Adler Global Ophthalmology Professor
BioDr. Jennifer Rose-Nussbaumer is a board-certified ophthalmologist and fellowship-trained cornea specialist at the Byers Eye Institute at Stanford University. Her clinical practice focuses on corneal transplantation, complex cataract surgery, and the treatment of infectious keratitis.
After completing her fellowship in Cornea and External Disease at the University of California, San Francisco (UCSF), Dr. Rose-Nussbaumer joined the faculty there and remained until 2021, when she transitioned to Stanford. What she loves most about medicine is caring for individual patients—building relationships, understanding each person's unique needs, and guiding them through their treatment with compassion and personalized attention.
In addition to her clinical work, Dr. Rose-Nussbaumer is an NIH-funded physician-scientist whose research centers on randomized clinical trials in ophthalmology. Her research is deeply rooted in her clinical practice: she is passionate about identifying the important, unanswered questions that arise while caring for patients, designing rigorous clinical trials to find the answers, and bringing that new knowledge back to the bedside to improve patient care.
She is the Principal Investigator on a UG1 grant supporting the **Descemet Endothelial Thickness Comparison Trial (DETECT)**, a randomized clinical trial comparing ultra-thin DSAEK (UT-DSAEK) to DMEK, and ripasudil to placebo, in patients with endothelial disease such as Fuchs Endothelial Dystrophy. She is also Principal Investigator on the **Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II)**, a randomized clinical trial conducted in collaboration with Aravind Eye Hospital in India and the University of São Paulo, evaluating the benefit of adjunctive topical steroids, corneal crosslinking, and rose bengal photodynamic therapy in the treatment of infectious corneal ulcers.
A native of Northern California, Dr. Rose-Nussbaumer enjoys spending time with her family and their Bernese Mountain Dog, Kenji, exploring the state's natural beauty through hiking and camping. -
Allyson Rosen, Ph.D., ABPP-CN
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioRESEARCH FOCUS
Translational cognitive neuroscience of aging and dementia. Neuroethics.
TRAINING
Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.
CLINICAL AND RESEARCH ACTIVITIES
Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.
ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
Ethics Review
http://www.j-alz.com/blogs/discussion/protecting-progress
MIRECC DEMENTIA EDUCATION
http://www.mirecc.va.gov/visn21/education/dementia_education.asp -
Craig S. Rosen, Ph.D.
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsMy research aims at improving processes and outcomes of mental health care for veterans other people suffering from post-traumatic stress and other mental disorders.
My primary focus is improving access to evidence-based treatments PTSD and other psychiatric disorders. My second emphasis is using telemedicine technologies to expand access to effective care. My third interest is measurement-based care, using ongoing data on patient progress to inform patients' and clinicians' decisions. -
Glenn Rosen
Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Emeritus
Current Research and Scholarly InterestsOur laboratory examines apoptotic and cell signaling pathways in cancer and lung disease. We are studying signaling pathways that regulate oxidative stress responses and cancer cell growth. Part of these studies focus on analysis of non-canonical transcription regulatory functions of the TERC and Tert components of telomerase in lung disease and cancer.
-
Michael J Rosen, MD, MSCI
Stanford University Endowed Professor for Pediatric IBD and Celiac Disease
BioDr. Rosen is a pediatric gastroenterologist and physician scientist who has been devoted to advancing inflammatory bowel disease (IBD) research and care for 25 years. He is the inaugural Stanford University Endowed Professor for Pediatric IBD and Celiac Disease. He is also Director of the Stanford Medicine Children’s Health Center for IBD and Celiac Disease, which has achieved nationally leading clinical outcomes under his direction. Dr. Rosen’s research expertise crosses mucosal immunology and epithelial biology and clinical and translational investigation. His NIH-funded laboratory has demonstrated the protective role for type 2 cytokines in chronic intestinal inflammation and advanced intestinal organoids as a model to study IBD. His clinical research has demonstrated how proactive therapeutic drug monitoring can be incorporated into clinical practice to optimize ant-TNF therapy treatment response. Dr. Rosen led the multicenter ARCH Study, which demonstrated the importance of intensified anti-TNF drug dosing in pediatric acute severe ulcerative colitis. Presently, he is co-principal investigator for the Crohn's & Colitis Foundation’s Cohort for Pediatric Translational and Clinical Research in IBD (CAPTURE IBD) which will advance precision medicine for children with IBD.
After graduating from Duke University, Dr. Rosen attended Harvard Medical School, followed by pediatrics residency at Boston Children’s Hospital and Boston Medical Center. He pursued his pediatric gastroenterology fellowship at Vanderbilt University Medical Center, where he received a Master of Science in Clinical Investigation. He started his faculty career at Vanderbilt and then moved to Cincinnati Children’s Hospital and the University of Cincinnati College of Medicine. There he rose to Medical Director of the Schubert Martin IBD Center and Associate Director for Faculty Development in the Gastroenterology division before moving to Stanford in 2021. Dr. Rosen serves on the editorial board for Inflammatory Bowel Diseases and the National Scientific Advisory Committee for the Crohn’s & Colitis Foundation. Outside of work, Dr. Rosen enjoys spending time with his wife and two children at their activities, watching movies, downhill skiing, and getting outside. -
David Rosenthal
Professor of Pediatrics (Pediatric Cardiology)
On Partial Leave from 2026-09-01 To 2027-04-15Current Research and Scholarly InterestsResearch interests include the study of Heart Failure, Cardiomyopathy and ventricular dysfunction in children, from a clinical perspective. Investigations include clinical trials of medications, cardiac resynchronization, and mechanical circulatory support.
-
Jason B. Ross, MD, PhD
Assistant Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory studies studying normal, dysfunctional, and malignant stem cells in the context of aging, cancer, and cancer therapies.
-
Jessica M. Ross, PhD
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psych/Public Mental Health & Population SciencesBioDr. Ross uses transcranial magnetic brain stimulation (TMS) and electroencephalography (EEG) for her research on neuromodulation-based psychiatric treatments, and on aberrant brain plasticity, cortical reactivity, and connectivity in older adults with cognitive disorder and healthy adults.
-
Fernanda Rossi, Ph.D.
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Rossi’s research focuses on developing, evaluating, and implementing assessment tools and interventions to improve the safety and mental health of individuals at risk of intimate partner violence, suicide, and drug overdose. She is particularly interested in using technology and clinical decision support tools to enhance the quality and implementation of intimate partner violence-, suicide-, and substance use-related care.
